Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women (NCT04237402) | Clinical Trial Compass
CompletedNot Applicable
Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women
France20 participantsStarted 2018-06-15
Plain-language summary
In this study, the investigator will try to highlight the presence of carbonyl compounds in the hair follicles of postpartum women by comparing these compounds before and after delivery.
Who can participate
Age range
18 Years – 40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Criteria related to the Population:
* Pregnant woman (≥ 33 weeks of amenorrhea)
* Woman aged between 18 and 40 years (included)
* Phototype I to IV included according to Fitzpatrick's classification
* Affiliation to a French social security scheme or benefiting from such a scheme
* Signed informed consent form
Exclusion Criteria:
Criteria related to the Population:
* High risk or pathological pregnancy, according to the opinion of the investigator
* Deprivation of liberty by administrative or judicial decision or subject under guardianship
* Impossibility, according to the investigator, to comply with the requirements of the protocol
* Linguistic or psychic incapacity to sign informed consent
* Concomitant participation in a clinical study that may interfere with the results of the study, according to the opinion of the investigator (excluding observational studies)
Criteria related to Pathology :
* Alopecia causing hair loss on the upper part of the scalp
* Dermatological pathology or evolving cutaneous lesion in the scalp
* Known history of hepatitis B and C, HIV
* Past or present neoplastic condition
* Acute evolving pathology
* Gestational diabetes treated with insulin
Criteria related to Treatments:
* Treatment of general thyroid disorders initiated or modified for less than 3 months prior to inclusion (or change of specialty for less than 3 months)
* Systemic treatment affecting hair growth taken for at least 4 weeks during the 3 months prio…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change of biological evaluation
Timeframe: 1st sample: inclusion visit (up to 8 weeks before delivery)- 2nd sample: end of study visit (10 to 16 weeks after delivery)